Biotech startup Inocucor closes in Series B funding round at $15.9 million to expand its R&D team
Biotech startup, Inocucor, today announced the final close of its Series B funding round at $15.9 million with participation by existing investors Cycle Capital Management (Montreal), Desjardins Innovatech (Montreal), TPG ART (San Francisco), and Pontifax AgTech (Los Angeles). Concurrently, the […]